Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Long-Term Deferred Tax (2019 - 2023)

Silo Pharma's Long-Term Deferred Tax history spans 5 years, with the latest figure at $2.5 million for Q4 2023.

  • For Q4 2023, Long-Term Deferred Tax rose 63.74% year-over-year to $2.5 million; the TTM value through Dec 2023 reached $2.5 million, up 63.74%, while the annual FY2023 figure was $2.5 million, 63.74% up from the prior year.
  • Long-Term Deferred Tax for Q4 2023 was $2.5 million at Silo Pharma, up from $1.6 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $2.5 million in Q4 2023 and bottomed at $609530.0 in Q4 2021.
  • The 5-year median for Long-Term Deferred Tax is $992271.0 (2020), against an average of $1.3 million.
  • The largest annual shift saw Long-Term Deferred Tax crashed 38.57% in 2021 before it surged 154.36% in 2022.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $614751.0 in 2019, then skyrocketed by 61.41% to $992271.0 in 2020, then plummeted by 38.57% to $609530.0 in 2021, then surged by 154.36% to $1.6 million in 2022, then soared by 63.74% to $2.5 million in 2023.
  • Per Business Quant, the three most recent readings for SILO's Long-Term Deferred Tax are $2.5 million (Q4 2023), $1.6 million (Q4 2022), and $609530.0 (Q4 2021).